BioSyent
(TSXV) RX
BioSyent Financials at a Glance
Market Cap
$165.91M
Revenue (TTM)
$43.05M
Net Income (TTM)
$9.01M
EPS (TTM)
$0.79
P/E Ratio
18.03
Dividend
$0.20
Beta (Volatility)
-0.03 (Low)
Dividend
$0.20
Beta (Volatility)
-0.03 (Low)
Price
$14.50
Volume
4,365
Open
$14.55
Price
$14.50
Volume
4,365
Open
$14.55
Previous Close
$14.43
Daily Range
$14.49 - $14.55
52-Week Range
$10.65 - $15.80
Dividend
$0.20
Beta (Volatility)
-0.03 (Low)
Price
$14.50
Volume
4,365
Open
$14.55
Previous Close
$14.43
Daily Range
$14.49 - $14.55
52-Week Range
$10.65 - $15.80
RX News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout BioSyent
Industry
Pharmaceuticals
Sector
Health CareEmployees
60
CEO
René C. Goehrum
Website
www.biosyent.comHeadquarters
Mississauga, ON L5N 6M1, CA
RX Financials
Key Financial Metrics (TTM)
Gross Margin
76%
Operating Margin
26%
Net Income Margin
21%
Return on Equity
24%
Return on Capital
27%
Return on Assets
18%
Earnings Yield
5.55%
Dividend Yield
1.42%
Payout Ratio
24.99%
Stock Overview
Market Cap
$165.91M
Shares Outstanding
11.50M
Volume
4.37K
Avg. Volume
5.24K
Financials (TTM)
Gross Profit
$32.11M
Operating Income
$11.31M
EBITDA
$12.17M
Operating Cash Flow
$9.62M
Capital Expenditure
$54.04K
Free Cash Flow
$9.57M
Cash & ST Invst.
$28.65M
Total Debt
$841.10K
BioSyent Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$9.67M
+9.9%
Gross Profit
$7.22M
+0.9%
Gross Margin
74.65%
N/A
Market Cap
$165.91M
N/A
Market Cap/Employee
$2.77M
N/A
Employees
60
N/A
Net Income
$1.99M
+23.5%
EBITDA
$2.62M
+4.6%
Quarterly Fundamentals
Net Cash
$27.81M
+86.6%
Accounts Receivable
$4.54M
+51.5%
Inventory
$6.42M
+20.4%
Long Term Debt
$626.74K
-25.5%
Short Term Debt
$214.36K
+9.0%
Return on Assets
18.23%
N/A
Return on Invested Capital
26.90%
N/A
Free Cash Flow
$3.80M
+46.0%
Operating Cash Flow
$3.82M
+45.9%